Disparities in the occurrence of late effects following treatment among adolescent and young adult melanoma survivors

Source: urbanhealthToday, August 2020

BACKGROUND: Melanoma is the third most common cancer in the adolescent and young adult (AYA) population, however no studies have addressed the occurrence of adverse health conditions following melanoma treatment in these survivors.

METHODS: Patients age 15-39 diagnosed with cutaneous melanoma from 1996-2012 and surviving ≤2 years were obtained from the California Cancer Registry and linked to statewide hospitalization data.

The influence of age at diagnosis, sex, race/ethnicity, neighborhood socioeconomic status (SES), health insurance, and surgery on the development of adverse health conditions was evaluated using Cox proportional hazards regression models.